5AM Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001799883 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $372M (100.0% shares, 0.0% debt)

Holdings (21)

CINCOR PHARMA INC 16.3%
Value $60.68M Shares 4,937,646 Est. Cost $19.40 Unrealized
TRDA ENTRADA THERAPEUTICS INC 16.0%
Value $59.6M Shares 4,408,379 Est. Cost $17.12 Unrealized
VOR BIOPHARMA INC 11.4%
Value $42.31M Shares 6,361,723 Est. Cost $43.10 Unrealized
RALLYBIO CORP 6.6%
Value $24.51M Shares 3,730,724 Est. Cost $17.58 Unrealized
IDYA IDEAYA BIOSCIENCES INC 5.8%
Value $21.74M Shares 1,196,298 Est. Cost $7.13 Unrealized +135.8%
PEAR THERAPEUTICS INC 5.3%
Value $19.76M Shares 16,744,113 Est. Cost $6.20 Unrealized
SCPHARMACEUTICALS INC 5.3%
Value $19.61M Shares 2,734,852 Est. Cost $5.92 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 4.2%
Value $15.78M Shares 862,286 Est. Cost $19.04 Unrealized -7.4%
RNAM AVIDITY BIOSCIENCES INC 4.0%
Value $14.77M Shares 665,555 Est. Cost $18.92 Unrealized -21.2%
IRON DISC MEDICINE INC 3.1%
Value $11.7M Shares 588,442 Est. Cost $49.79 Unrealized 0.0%
ANAB ANAPTYSBIO INC 3.0%
Value $11.09M Shares 357,733 Est. Cost $28.24 Unrealized 0.0%
ARVN ARVINAS INC 2.9%
Value $10.95M Shares 320,000 Est. Cost $29.28 Unrealized +43.7%
IMPEL NEUROPHARMA INC 2.9%
Value $10.82M Shares 2,884,791 Est. Cost $8.85 Unrealized
COGT COGENT BIOSCIENCES INC 2.5%
Value $9.137M Shares 790,440 Est. Cost $6.91 Unrealized +79.3%
VRDN VIRIDIAN THERAPEUTICS INC 2.4%
Value $8.763M Shares 300,000 Est. Cost $17.98 Unrealized +28.2%
IVERIC BIO INC 2.2%
Value $8.235M Shares 384,626 Est. Cost $16.46 Unrealized
PHVS PHARVARIS N V 1.8%
Value $6.611M Shares 587,600 Est. Cost $18.63 Unrealized -71.8%
JANX JANUX THERAPEUTICS INC 1.6%
Value $5.877M Shares 446,266 Est. Cost $22.27 Unrealized -34.3%
HOMOLOGY MEDICINES INC 1.5%
Value $5.715M Shares 4,535,919 Est. Cost $20.70 Unrealized
FIBROGEN INC 1.0%
Value $3.614M Shares 225,583 Est. Cost $16.02 Unrealized
CIDARA THERAPEUTICS INC 0.2%
Value $858K Shares 1,134,511 Est. Cost $3.84 Unrealized